Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our passionate
Director / Senior Director, Medicinal Chemistry Full-time About us Ridgeline Discovery, a Versant Ventures Discovery Engine, creates and operates Versant-financed innovative biotech companies in partnership with entrepreneurs, industry, and leading academics across Europe. In recent years,
MDPI seeks a Senior Product Manager to own mdpi.com, our flagship publishing platform serving millions of researchers worldwide. Shape strategy, balance editorial, engineering, marketing and data teams, and drive scalable, user-centric improvements.You will lead discovery, define OKRs,
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS‑addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
DTAS Strategic Advisory Consulting ( Life Sciences Supply Chain & Operations ) IQVIA is The Human Data Science Company, focused on using data and science to help healthcare clients find better solutions for their patients. IQVIA
Adobe Basel seeks a Principal Engineering Program Manager to shape AI-native engineering programs at scale. You will oversee cross-functional initiatives from planning to release, building systems that enable rapid delivery while maintaining control.Partner with senior leaders, establish clear
About us Ridgeline Discovery , a Versant Ventures Discovery Engine, creates and operates Versant-financed innovative biotech companies in partnership with entrepreneurs, industry, and leading academics across Europe. In recent years, Ridgeline has assembled an international team